Genetic correlates of therapeutic toxicities of stage III colon cancer (CC) patients treated with adjuvant FOLFOX+/-cetuximab (Alliance NCCTG N0147)
- Citation:
- J Clin Oncol vol 35 (15 suppl) abstr 3604
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 3234
- Pharmas:
- Sanofi, Eli Lilly
- Grants:
- U10CA180821, U10CA180882, U10CA180820, U10CA180863, U10CA180888, CCSRI 021039
- Corr. Author:
- Authors:
- Polly A. Newcomb Wei Sun Xinwei Hua Barbara Banbury Amanda I. Phipps Jonathan M. Kocarnik Tabitha A. Harrison Qian Shi Frank Sinicrope Steve Thibodeau Emily Chan Sharlene Gill Richard M. Goldberg Morton Kahlenberg Suresh Nair Anthony Shields Ulrike Peters Steve R. Alberts Andrew T. Chan
- Networks:
- LAPS-MN026, LAPS-OH007, MCRC
- Study
- NCCTG-N0147
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: